IQVIA Holdings Inc.
IQVIA Holdings Inc. (NYSE: IQV) is a $44.7B medical - diagnostics & research company trading at $271.62 — 34.6× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-04 12:39 UTC.
IQVIA Holdings Inc. (NYSE: IQV) is a $44.7B medical - diagnostics & research company trading at $271.62 — 34.6× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-04 12:39 UTC.
IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare companies. The company operates one of the world's largest healthcare information collections, including comprehensive patient records and data from numerous suppliers across many countries, which it processes through advanced analytics and proprietary technology infrastructure.
Summarized from IQVIA Holdings Inc.’s SEC filings · Read the filing ↗
| Quote | |
| Price | $271.62 |
| Market cap | $44.7B |
| Volume | 2.01M shares |
| 52-week range | $154.50 – $271.69 |
| Valuation | |
| P/E (TTM) | 34.65× |
| EV/EBITDA | 17.60× |
| EPS (TTM) | $7.84 |
| Price/book | 6.88× |
| Return on equity | 20.91% |
| Debt/equity | 2.42 |
| Returns | |
| 52-week return | +75.8% |
Iqvia Holdings Inc. (IQV) reported 2 operating metrics for Q1 2026 in its SEC earnings exhibit filed 2026-05-05.
Most recent reported period: Q1 2026, filed 2026-05-05.
| Net book-to-bill | 1.11x |
See how IQV compares across the industry →
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
| Revenue growth | +8.4% |
Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely.
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare companies.
IQV trades at $271.62, 34.65× trailing earnings, 17.60× EV/EBITDA, as of 2026-09-04.
IQVIA Holdings Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-11. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-09-04 12:39 UTC. This page is also available as JSON at /api/data?ticker=IQV and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for IQV and 5,000+ tickers.
Create a free account — keep IQVGET /api/data?ticker=IQV
This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt